The EORTC CLTF 20-21 Meeting took place from 14-16 October, 2021, as both a live meeting in Marseille, France, and as a virtual event. This meeting covered the latest updates in cutaneous lymphoma.

Related content: Managing CD30+ CTCL: UK patient experience

Managing CD30+ CTCL - UK Patient Experience
View all videos

EORTC CLTF 2021

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 20-21 Meeting
14–16 October 2021 | Hybrid: Marseille, France & Virtual

💥New: Phase III INDEPENDENCE trial of luspatercept in patients with TD #Myelofibrosis on JAKi therapy💥

Ruben Mesa (@mpdrc) of @UTHealthSAMDA talks on the rationale & design of the currently enrolling study: http://ow.ly/4I5F50HzL3b

#ASH21 #HemOnc #MPNsm #TrialUpdate #CTSM

The latest Lymphoma: Today! https://paper.li/chanyooncheah/1505376789?edition_id=e9b006b0-7db6-11ec-aab8-fa163ed80008 Thanks to @VJHemOnc @smbenlazar @lymphomahub #lymphoma #lymsm

The 2022 4th European CAR T-Cell Meeting is fast approaching – are you ready to be a part of this great experience 🤩? Stay tuned with us @VJHemOnc for regular updates!

@TheEBMT @EHA_Hematology #CART22 #CARTtherapy #ImmunoOnc #HemOnc #tcellrx #MMsm #LYMsm #AMLsm #CARTcell

Today is #BPDCNDay {1-23, #CD123}. Please help me raise awareness for research&novel therapeutics for our patients,families&caregivers facing #BPDCN. I have dedicated my life & career for this cause&will always keep going for you! @lane_andy @JoeKhouryMD @sanamloghavi @tmprowell

4

A study of 61,437 people with myeloma: 3783 from @MayoClinic and 57,654 from SEER Registry shows remarkable improvement in overall survival of myeloma over time. @MoritzBinderMD @LeukemiaJnl @MayoCancerCare @MayoMyeloma https://www.nature.com/articles/s41375-021-01453-5

Load More...

EORTC CLTF 2021

The European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 20-21 Meeting
14–16 October 2021 | Hybrid: Marseille, France & Virtual

The EORTC CLTF 20-21 Meeting took place from 14-16 October, 2021, as both a live meeting in Marseille, France, and as a virtual event. This meeting covered the latest updates in cutaneous lymphoma.

Related content: Managing CD30+ CTCL: UK patient experience

Managing CD30+ CTCL - UK Patient Experience
View all videos

💥New: Phase III INDEPENDENCE trial of luspatercept in patients with TD #Myelofibrosis on JAKi therapy💥

Ruben Mesa (@mpdrc) of @UTHealthSAMDA talks on the rationale & design of the currently enrolling study: http://ow.ly/4I5F50HzL3b

#ASH21 #HemOnc #MPNsm #TrialUpdate #CTSM

The latest Lymphoma: Today! https://paper.li/chanyooncheah/1505376789?edition_id=e9b006b0-7db6-11ec-aab8-fa163ed80008 Thanks to @VJHemOnc @smbenlazar @lymphomahub #lymphoma #lymsm

The 2022 4th European CAR T-Cell Meeting is fast approaching – are you ready to be a part of this great experience 🤩? Stay tuned with us @VJHemOnc for regular updates!

@TheEBMT @EHA_Hematology #CART22 #CARTtherapy #ImmunoOnc #HemOnc #tcellrx #MMsm #LYMsm #AMLsm #CARTcell

Today is #BPDCNDay {1-23, #CD123}. Please help me raise awareness for research&novel therapeutics for our patients,families&caregivers facing #BPDCN. I have dedicated my life & career for this cause&will always keep going for you! @lane_andy @JoeKhouryMD @sanamloghavi @tmprowell

4

A study of 61,437 people with myeloma: 3783 from @MayoClinic and 57,654 from SEER Registry shows remarkable improvement in overall survival of myeloma over time. @MoritzBinderMD @LeukemiaJnl @MayoCancerCare @MayoMyeloma https://www.nature.com/articles/s41375-021-01453-5

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter